Karen Juul Mylam

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

Tarec Christoffer El‐Galaly, Francesco d’Amore, Karen Juul Mylam et al. · Journal of Clinical Oncology · 2012 · 283 citations · Full text

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study

Tarec Christoffer El‐Galaly, Lasse Hjort Jakobsen, Martin Hutchings et al. · Journal of Clinical Oncology · 2015 · 93 citations · Full text

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy

Tarec Christoffer El‐Galaly, Diego Villa, Thomas Yssing Michaelsen et al. · European Journal of Cancer · 2017 · 92 citations

Positron Emission Tomography, Neuro-oncology, Lymphoid Neoplasia +11

Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs

Tarec Christoffer El‐Galaly, Karen Juul Mylam, Peter de Nully Brown et al. · Haematologica · 2011 · 81 citations · Full text

Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B‐cell lymphoma is associated with poor outcomes and a high frequency of secondary <scp>CNS</scp> involvement

Tarec Christoffer El‐Galaly, Chan Y. Cheah, Martin Hutchings et al. · British Journal of Haematology · 2016 · 43 citations · Full text